tiprankstipranks
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
Holding CTMX?
Track your performance easily

CytomX Therapeutics (CTMX) Technical Analysis

585 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
CytomX Therapeutics Inc’s (CTMX) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting CytomX Therapeutics Inc is a Buy.
CytomX Therapeutics Inc’s (CTMX) 20-Day exponential moving average is 1.11, while CytomX Therapeutics Inc’s (CTMX) share price is $1.09, making it a Sell.
CytomX Therapeutics Inc’s (CTMX) 50-Day exponential moving average is 1.10, while CytomX Therapeutics Inc’s (CTMX) share price is $1.09, making it a Sell.

CytomX Therapeutics (CTMX) Pivot Points

Dec 21, 2024, 04:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.94
0.99
1.04
1.09
1.14
1.19
1.24
Fibonacci
0.99
1.02
1.05
1.09
1.12
1.15
1.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

CytomX Therapeutics (CTMX) Moving Averages

Dec 21, 2024, 04:22 PM
Period
Simple
Exponential
MA5
1.11Sell
1.10Sell
MA10
1.14Sell
1.12Sell
MA20
1.12Sell
1.11Sell
MA50
1.07Buy
1.10Sell
MA100
1.13Sell
1.18Sell
MA200
1.51Sell
1.43Sell
CytomX Therapeutics Inc’s (CTMX) 10-Day exponential moving average is 1.12, while CytomX Therapeutics Inc’s (CTMX) share price is $1.09, making it a Sell.
CytomX Therapeutics Inc’s (CTMX) 100-Day exponential moving average is 1.18, while CytomX Therapeutics Inc’s (CTMX) share price is $1.09, making it a Sell.
CytomX Therapeutics Inc’s (CTMX) stock price is $1.09 and CytomX Therapeutics Inc’s (CTMX) 50-day simple moving average is 1.07, creating a Buy signal.
CytomX Therapeutics Inc’s (CTMX) stock price is $1.09 and CytomX Therapeutics Inc’s (CTMX) 100-day simple moving average is 1.13, creating a Sell signal.
CytomX Therapeutics Inc’s (CTMX) stock price is $1.09 and CytomX Therapeutics Inc’s (CTMX) 200-day simple moving average is 1.51, creating a Sell signal.

CytomX Therapeutics (CTMX) Technical Indicators

Dec 21, 2024, 04:22 PM
Name
Value
Implied Action
RSI (14)
49.29
Neutral
STOCH (9,6)
31.05
Neutral
STOCHRSI (14)
19.84
Buy
MACD (12,26)
0.02
Buy
ADX (14)
19.70
Buy
Williams %R
-78.57
Buy
CCI (14)
-31.72
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
59.44
Neutral
ROC
0.00
-
CytomX Therapeutics Inc’s (CTMX) Relative Strength Index (RSI) is 49.29, creating a Neutral signal.
CytomX Therapeutics Inc’s (CTMX) Trend Strength Indicator (ADX) is 19.70, creating a Buy signal.
CytomX Therapeutics Inc’s (CTMX) Commodity Channel Index (CCI) is -31.72, creating a Neutral signal.

FAQ

Is CTMX a Buy, Hold, or Sell?
Based on CTMX’s technical indicators, CTMX is a Sell.
    What is CTMX’s RSI (14)?
    CTMX’s RSI (14) is 49.29, which suggests CTMX is a Neutral.
      What is CTMX’s MACD?
      CTMX’s MACD is 0.02, which suggests CTMX is a Buy.
        What is CTMX’s 5-day moving average?
        CTMX’s 5-day moving average is 1.11, which suggests CTMX is a Sell.
          What is CTMX’s 20-day moving average?
          CTMX 20-day moving average is 1.12, which suggests CTMX is a Sell.
            What is CTMX’s 50-day moving average?
            CTMX’s 50-day moving average is 1.07, which suggests CTMX is a Buy.
              What is CTMX’s 200-day moving average?
              CTMX’s 200-day moving average is 1.51, which suggests CTMX is a Sell.
                What is CTMX’s Williams % R (14)?
                CTMX’s Williams % R (14) is -78.57, which suggests CTMX is a Buy.
                  What is CTMX’s CCI (14)?
                  CTMX’s CCI (14) is -31.72, which suggests CTMX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis